SCHEMBL6203750

SCHEMBL6203750

COc1ccc2[nH]c3c(c2c1)C(=O)c1cc(OC)c(OC)cc1-3

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.50
KDM4E B2RXH2 6/20 0.50
MAPT P10636 4/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
HSD17B10 Q99714 2/20 0.50
ABCG2 Q9UNQ0 1/20 0.50
TSHR P16473 1/20 0.50
GFER P55789 1/20 0.50
CDK1 P06493 5/20 0.48
CCNB1 P14635 5/20 0.48
GSK3B P49841 5/20 0.48
CCNB2 O95067 4/20 0.48
CDK5 Q00535 4/20 0.48
CDK5R1 Q15078 4/20 0.48
CCNB3 Q8WWL7 4/20 0.48
GSK3A P49840 3/20 0.48
HPGD P15428 4/20 0.48
MTNR1A P48039 1/20 0.47
MTNR1B P49286 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7234662 0.99 ABCG2 (0.49) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL6203623 0.85 WEE1 (0.47) MEN1KMT2ACDK1CCNB1GSK3B
SCHEMBL6200212 0.84 CA1 (0.52) ALDH1A1KDM4EMAPTMEN1KMT2A
Hydrochloric Acid SCHEMBL7227282 0.84 WEE1 (0.46) MEN1KMT2ACDK1CCNB1GSK3B
SCHEMBL6496527 0.84 CTSV (0.51)
SCHEMBL6203062 0.84 PARP1 (0.46) ALDH1A1KDM4EHSD17B10HPGDPDGFRB
Hydrochloric Acid SCHEMBL7226744 0.83 CA1 (0.51) ALDH1A1KDM4EMAPTMEN1KMT2A
Hydrochloric Acid SCHEMBL7235812 0.83 PARP1 (0.45) ALDH1A1KDM4EHSD17B10HPGDPDGFRB
SCHEMBL17817279 0.82 ABCG2 (0.58) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL6203624 0.80 TLR8 (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1266887-B1 Indenoindoline derivatives, their process of preparation and pharmaceutical compositions containing them SERVIER LAB (FR) 2005-08-17 EP disclosed
US-6844445-B2 Indenoindolone compounds LES LABORATOIRES SERVIER (FR) 2005-01-18 US disclosed
EP-1245565-B1 Indenoindolone derivatives, process for their preparation and pharmaceutical compositions containing them SERVIER LAB (FR) 2003-09-24 EP disclosed
EP-1266887-A2 Indenoindoline derivatives, their process of preparation and pharmaceutical compositions containing them Les Laboratoires Servier (FR) 2002-12-18 EP disclosed
US-20020173531-A1 Indenoindolone compounds LES LABORATOIRES SERVIER (FR) 2002-11-21 US disclosed
EP-1245565-A1 Indenoindolone derivatives, process for their preparation and pharmaceutical compositions containing them Les Laboratoires Servier (FR) 2002-10-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020173531-A1 Indenoindolone compounds MTNR1A, MTNR1B, CYP11B1 ALDH1A1 232/4885KDM4E 3234/4885MAPT 2618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.